Cancer immunology and microenvironment (IMM)

The immune system in the tumor microenvironment: Inflammation in tumor progression; Functional role of tumor-associated leukocytes and other host cells; Immune infiltrate and tumor angiogenesis; Effects of the tumor on local and systemic immune regulation; Tumor-associated regulatory T cells; Tumor-associated suppressor cells of the myeloid lineage (MDSC, TAM, TAN); Tertiary lymphoid structures in the tumor; Therapeutic approaches targeting the tumor microenvironment.
Medical oncology:
Cancer immunology and immunotherapy in solid tumors: History and principles of immune cancer treatment; Predictors of response to immune therapies; Development of anticancer immune agents;
Evidence of efficacy of immune therapies; Immunotherapies in different models of solid cancers; T-cell therapies; Cancer vaccines; Future trends in cancer immune therapy; Toxicity of cancer immune therapies; Sustainability of anticancer agents.
Blood diseases:
Cancer immunology and immunotherapy in hematological tumors: The role of checkpoint inhibitors in Lymphomas; Adoptive immunotherapy for cancer (CAR T cells); Allogenic hematopoietic stem cell transplantation as adoptive immunotherapy in cancer; The targeting of cancer microenvironment (T-reg, MDSC, NK, Dendritic, macrophages): the paradigma of multiple myeloma; The role of the B-cell receptor signaling in lymphoid malignancies.